title: Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications.
authors.affiliation: Institute for Clinical Evaluative Sciences, Toronto, ON. muhammad.mamdani@ices.on.ca
authors.forename: Muhammad
authors.initials: M
authors.lastname: Mamdani
authors.forename: Paula
authors.initials: P
authors.lastname: Rochon
authors.forename: Andreas
authors.initials: A
authors.lastname: Laupacis
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Anderson
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D005260:Female; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000191:economics; D008297:Male; D010003:Osteoarthritis / Q000188:drug therapy* / Q000191:economics; D011720:Pyrazoles; D013449:Sulfonamides / Q000008:administration & dosage / Q000191:economics; D013450:Sulfones
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib